Atlas Trials

Glycogenosis 2

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Glycogenosis 2

RecordFirmDate
A Noninferiority Study of Alglucosidase Alfa Manufactured at the 160 L and 4000 L Scales in Treatment Naïve Patients With Infantile-Onset Pompe Disease (NCT01597596)Genzyme, a Sanofi Company2012-08-01
Safety and Effectiveness Study of rhGAA in Patients With Advanced Late-Onset Pompe Disease Receiving Respiratory Support (NCT00268944)Genzyme, a Sanofi Company2005-12-01
A Placebo-Controlled Study of Safety and Effectiveness of Myozyme (Alglucosidase Alfa) in Patients With Late-Onset Pompe Disease (NCT00158600)Genzyme, a Sanofi Company2005-09-01
A Study of rhGAA in Patients With Late-Onset Pompe Disease (NCT00250939)Genzyme, a Sanofi Company2005-02-01
Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Late-onset Pompe Disease (NCT00074932)Genzyme, a Sanofi Company2004-11-01
Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Infantile-onset Pompe Disease (NCT00074919)Genzyme, a Sanofi Company2003-12-01
rhGAA in Patients With Infantile-onset Glycogen Storage Disease-II (Pompe Disease) (NCT00053573)Genzyme, a Sanofi Company2003-02-01
A Study of the Safety and Pharmacokinetics of rhGAA in Siblings With Glycogen Storage Disease Type II (NCT00051935)Genzyme, a Sanofi Company2003-01-01
Safety and Efficacy of Recombinant Human Acid Alpha-Glucosidase in the Treatment of Classical Infantile Pompe Disease (NCT00025896)Genzyme, a Sanofi Company2001-05-01
Alglucosidase Alfa Temporary Access Program (NCT00520143)Genzyme, a Sanofi Company

Track Glycogenosis 2 automatically

Every clearance here is in the API, with alerts when new ones post.